Microalbuminuria and early endothelial activation in essential hypertension

被引:29
作者
Cottone, S.
Mule, G.
Nardi, E.
Lorito, M. C.
Guarneri, M.
Arsena, R.
Briolotta, C.
Vadala, A.
Cerasola, G.
机构
[1] Univ Palermo, Unita Operat Med Interna Nefrol & Ipertens, Palermo, Italy
[2] Univ Palermo, Dipartimento Med Interna Malattie Cardiovasc & Ne, Cattedra Med Interna, Palermo, Italy
关键词
endothelial dysfunction; adhesion molecules; microalbuminuria; essential hypertension;
D O I
10.1038/sj.jhh.1002109
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We hypothesized that in essential hypertensive patients (EHs), plasma levels of pro-atherogenic adhesion molecules would be increased and related with urine albumin excretion (UAE). Thus, this study was aimed at evaluating biochemical markers of endothelial activation and their relationship with UAE in a group of patients with uncomplicated EH. In basal condition soluble forms of adhesion molecules intercellular adhesion molecule ( ICAM)-1 and vascular cell adhesion molecule ( VCAM)-1, as well as 24-h UAE were assayed. One hundred patients with essential hypertension and no diabetes or ultrasonographic evidence of atherosclerosis were included in the study. Seventy normotensive healthy subjects served as controls. EHs were first studied overall, than were divided into two subgroups: those with UAE >= 20 mcg/min MAUs and those with UAE <20 mcg/min (non-MAUs). ICAM-1 (P<0.001) and VCAM-1 (P<0.0001) plasma concentrations were higher in EHs than in controls. Microalbuminuric EHs had greater levels of adhesion molecules than non-MAUs (ICAM-1 P = 0.04; VCAM-1 P = 0.02, respectively). In EHs UAE was correlated with ICAM-1 ( r = 0.29, P = 0.003), and VCAM-1 ( r = 0.30, P = 0.002). These associations were confirmed in multiple regression models ( P = 0.02 for both ICAM-1 and VCAM-1) including, along with adhesion molecules, age, body mass index and blood pressures. Our findings show that in essential hypertension there is a very early activation of endothelial adhesion molecules favouring atherosclerosis.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 37 条
[1]   Assessment and treatment of endothelial dysfunction in humans [J].
Anderson, TJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (03) :631-638
[2]   SYSTEMIC NATURE OF ENDOTHELIAL DYSFUNCTION IN ATHEROSCLEROSIS [J].
ANDERSON, TJ ;
GERHARD, MD ;
MEREDITH, IT ;
CHARBONNEAU, F ;
DELAGRANGE, D ;
CREAGER, MA ;
SELWYN, AP ;
GANZ, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (06) :B71-B74
[3]  
ARMITAGE P, 1987, STAT METHODS MED RES, P304
[4]   Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study [J].
Ärnlöv, J ;
Evans, JC ;
Meigs, JB ;
Wang, TJ ;
Fox, CS ;
Levy, D ;
Benjamin, EJ ;
D'Agostino, RB ;
Vasan, RS .
CIRCULATION, 2005, 112 (07) :969-975
[5]   Is C-reactive protein an independent risk factor for essential hypertension? [J].
Bautista, LE ;
López-Jaramillo, P ;
Vera, LM ;
Casas, JP ;
Otero, AP ;
Guaracao, AI .
JOURNAL OF HYPERTENSION, 2001, 19 (05) :857-861
[6]   Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications [J].
Bianchi, S ;
Bigazzi, R ;
Campese, VM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :973-995
[7]   A longitudinal prospective study of soluble adhesion molecules in acute stroke [J].
Bitsch, A ;
Klene, W ;
Murtada, L ;
Prange, H ;
Rieckmann, P .
STROKE, 1998, 29 (10) :2129-2135
[8]   Blood pressure, C-reactive protein, and risk of future cardiovascular events [J].
Blake, GJ ;
Rifai, N ;
Buring, JE ;
Ridker, PM .
CIRCULATION, 2003, 108 (24) :2993-2999
[9]   Circulating cell adhesion molecules and death in patients with coronary artery disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Bickel, C ;
Peetz, D ;
Hafner, G ;
Tiret, L ;
Meyer, J .
CIRCULATION, 2001, 104 (12) :1336-1342
[10]  
BLANN AD, 1993, J HUM HYPERTENS, V7, P107